Navigation Links
Global $11.93 Billion Pharmacogenomics Market 2014-2017 & 2024 - Research and Markets
Date:4/20/2017

DUBLIN, April 20, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2014 to 2024" report to their offering.

The global pharmacogenomics market was valued at US$ 7,167.6 Mn in 2015, and is expected to reach US$ 11,938.8 Mn by 2024, expanding at a CAGR of 5.6% from 2016 to 2024.

The global pharmacogenomics market is segmented based on technology type as microarray, sequencing, polymerase chain reaction and other technologies. Sequencing dominates the market, especially with the advent of next generation sequencing attributed by high throughput screening, high accuracy and speed.

Scope of the Report

Microarray

Sequencing:
- Sanger Sequencing
- Pyrosequencing
- Next-Generation Sequencing

Polymerase Chain Reaction

Other Technologies:
- Mass Spectrometry
- Electrophoresis

The global pharmacogenomics market is further segmented in terms of therapeutic application such as oncology, cardiology, psychiatry, infectious diseases, pain management, neurological disorders and others. Among these, oncology segment dominates the therapeutic market followed by psychiatry and infectious diseases.

Currently, North America occupies the largest revenue share for global pharmacogenomics market, largely dominated by the U.S. Major growth drivers of North America market are presence of extensive and evolved healthcare infrastructure, increasing preference for better, cost effective and personalized therapeutics for various diseases and infections. Asia Pacific is expected to be the most attractive regional market and is anticipated to witness extensive growth during the forecast period.

Key Market Movements:

  • Focus on personalized medicine emphasizing on the paradigm shift in medicine from reaction to prevention. Able to design unique disease prevention strategies, prescribe more effective drugs and reduce the ADR's, enhance quality of life, increase patient compliance.
  • Recently, pharmacogenomics have being extensively used in drug development. It is used at various stages of drug development assessing and identifying effect of drug target polymorphisms on drug response.
  • Discovery of new biological mechanisms and identification of molecules with improved efficacy and safety

Market Dynamics

Market Drivers

  • Rise in investment in research and development
  • Advancement in technology pharmacogenomics engineering to create in vivo environment

Challenge

  • Lack of consistency in pharmacogenomics products

Opportunities

  • Focus on regenerative medicine
  • Increased awareness of organ transplantation

Key Topics Covered:

1. Preface

2. Executive Summary

3. Market Overview and Future Outlook

4. Global Pharmacogenomics Market, By Technology, 2014 - 2024 (US$)

5. Global Pharmacogenomics Market, By Application, 2014 - 2024 (US$)

6. Global Pharmacogenomics Market, By Geography, 2014 - 2024 (US$)

7. Company Profiles

  • Abbott Laboratories, Inc.
  • Affymetrix, Inc.
  • AstraZeneca plc
  • Assurex Health
  • Bayer AG
  • GeneDX
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc
  • Myriad Genetics, Inc
  • Merck & Co
  • GE Healthcare
  • GlaxoSmithKline
  • Johnson & Johnson
  • Pfizer, Inc.
  • Pathway Genomics
  • Qiagen, Inc.
  • Teva Pharmaceutical Industries Ltd
  • Thermo Fisher Scientific
  • Transgenomic, Inc.

For more information about this report visit http://www.researchandmarkets.com/research/g65nsk/global

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 



To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-1193-billion-pharmacogenomics-market-2014-2017--2024---research-and-markets-300442497.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Information Online Market Research Portal Provides Complimentary Sample Service for Customers to Preview Reports by Global Industry Analysts
2. Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
3. The Rockley Group and Content Rules Ink Deal to Extend Global Reach
4. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
5. Amgen To Present At The UBS Global Life Sciences Conference
6. HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
7. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City
8. PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems
9. Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
10. TRACE Releases 2012 Global Enforcement Report
11. Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... 2017  Bayer has awarded grants totaling more than $2 ... its prestigious Bayer Hemophilia Awards Program (BHAP). Four U.S. clinicians ... and Uniformed Services University of the Health Sciences ... Grant recipients were announced last night during a reception at ... Berlin, Germany . ...
(Date:7/10/2017)... 2017  US medical equipment and supply demand is ... Medical Equipment & Supplies: United States ... Continued increases in demand for medical services – driven ... and supported by gains in disposable personal income – ... product introductions will also drive sales as providers and ...
(Date:7/6/2017)... nutrition division of Diplomat Specialty Infusion Group, is celebrating a decade of ... To celebrate its anniversary, ThriveRx recently launched a redesigned website at ... organization to create the best user experience for consumers and health care ... Diplomat Pharmacy ... "We,ve made several great strides throughout the past 10 ...
Breaking Medicine Technology:
(Date:7/21/2017)... LOUIS, MO (PRWEB) , ... July 21, 2017 , ... ... born knowing how to tie their shoes,” says Suzanne Tucker, Founder of St. Louis-based ... the Time-In Toolkit, which launches on Kickstarter on Monday, July 21st. , The ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased to announce ... Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network of medical ... dermatology, skin cancer , and more. She graduated from the University of Florida ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... ligament (ACL) offer patients improved quality of life five years after injury, according ... Annual Meeting in Toronto, Ontario, Canada. The study followed patients for five ...
(Date:7/20/2017)... ... July 20, 2017 , ... TransPixel Volume 2 is ... clips in the FCPX timeline. This effect isolates horizontal and vertical lines of pixels ... contains either a rotating or flipping animation and can be changed using a drop-down ...
(Date:7/20/2017)... MA (PRWEB) , ... July 20, 2017 , ... ... form of blood and bone marrow cancer that progresses rapidly without treatment. Newly ... recommended to reduce the chance of reoccurrence and relapse. With such a ...
Breaking Medicine News(10 mins):